1. |
McDonagh TA, Metra M, Adamo M, et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J, 2021, 42(36): 3599-3726.
|
2. |
Sinnenberg L, Givertz MM. Acute heart failure. Trends Cardiovasc Med, 2020, 30(2): 104-112.
|
3. |
Adams KF Jr, Fonarow GC, Emerman CL, et al. Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100, 000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE). Am Heart J, 2005, 149(2): 209-216.
|
4. |
Krumholz HM, Merrill AR, Schone EM, et al. Patterns of hospital performance in acute myocardial infarction and heart failure 30-day mortality and readmission. Circ Cardiovasc Qual Outcomes, 2009, 2(5): 407-413.
|
5. |
Ambrosy AP, Pang PS, Khan S, et al. Clinical course and predictive value of congestion during hospitalization in patients admitted for worsening signs and symptoms of heart failure with reduced ejection fraction: findings from the EVEREST trial. Eur Heart J, 2013, 34(11): 835-843.
|
6. |
中华医学会心血管病学分会心力衰竭学组, 中国医师协会心力衰竭专业委员会, 中华心血管病杂志编辑委员会. 中国心力衰竭诊断和治疗指南 2018. 中华心血管病杂志, 2018, 46(10): 760-789.
|
7. |
Palazzuoli A, Testani JM, Ruocco G, et al. Different diuretic dose and response in acute decompensated heart failure: clinical characteristics and prognostic significance. Int J Cardiol, 2016, 224: 213-219.
|
8. |
Palazzuoli A, Ruocco G, Beltrami M, et al. Combined use of lung ultrasound, B-type natriuretic peptide, and echocardiography for outcome prediction in patients with acute HFrEF and HFpEF. Clin Res Cardiol, 2018, 107(7): 586-596.
|
9. |
Palazzuoli A, Evangelista I, Beltrami M, et al. Clinical, laboratory and lung ultrasound assessment of congestion in patients with acute heart failure. J Clin Med, 2022, 11(6): 1642.
|
10. |
Grant SW, Collins GS, Nashef SAM. Statistical primer: developing and validating a risk prediction model. Eur J Cardiothorac Surg, 2018, 54(2): 203-208.
|
11. |
Bonnett LJ, Snell KIE, Collins GS, et al. Guide to presenting clinical prediction models for use in clinical settings. BMJ, 2019, 365: I737.
|
12. |
Staffa SJ, Zurakowski D. Statistical development and validation of clinical prediction models. Anesthesiology, 2021, 135(3): 396-405.
|
13. |
Zhang J, Wang L, Zhao Z, et al. Correlation between levels of serum lipoprotein-associated phospholipase A2 and soluble suppression of tumorigenicity 2 and condition of acute heart failure patients and their predictive value for prognosis. J Healthc Eng, 2021, 2021: 1525190.
|
14. |
Öhman J, Harjola VP, Karjalainen P, et al. Assessment of early treatment response by rapid cardiothoracic ultrasound in acute heart failure: cardiac filling pressures, pulmonary congestion and mortality. Eur Heart J Acute Cardiovasc Care, 2018, 7(4): 311-320.
|
15. |
Espersen C, Campbell RT, Claggett B, et al. Sex differences in congestive markers in patients hospitalized for acute heart failure. ESC Heart Fail, 2021, 8(3): 1784-1795.
|
16. |
Biegus J, Voors AA, Collins SP, et al. Impact of empagliflozin on decongestion in acute heart failure: the EMPULSE trial. Eur Heart J, 2022: ehac530.
|
17. |
Gheorghiade M, Follath F, Ponikowski P, et al. Assessing and grading congestion in acute heart failure: a scientific statement from the acute heart failure committee of the heart failure association of the European Society of Cardiology and endorsed by the European Society of Intensive Care Medicine. Eur J Heart Fail, 2010, 12(5): 423-433.
|
18. |
Corrêa TD, Sanches PR, de Morais LC, et al. Performance of noninvasive ventilation in acute respiratory failure in critically ill patients: a prospective, observational, cohort study. BMC Pulm Med, 2015, 15: 144.
|
19. |
Vincent JL, Opal SM, Marshall JC. Ten reasons why we should NOT use severity scores as entry criteria for clinical trials or in our treatment decisions. Crit Care Med, 2010, 38(1): 283-287.
|